SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-044375
Filing Date
2009-03-04
Accepted
2009-03-04 08:30:33
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 920420
2 CONSENT dex231.htm EX-23.1 1631
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 1523
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7505
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7535
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2606
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2654
  Complete submission text file 0001193125-09-044375.txt   945340
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51462 | Film No.: 09653891
SIC: 2836 Biological Products, (No Diagnostic Substances)